发明名称 POLYPEPTIDES COMPRISING A MODIFIED BACTERIOPHAGE G3P AMINO ACID SEQUENCE WITH REDUCED IMMUNOGENICITY.
摘要 The invention relates to polypeptides that comprise a portion of filamentous bacteriophage gene 3 protein (g3p) sufficient to bind to and/or disaggregate amyloid, e.g., the N1-N2 portion of g3p and mutants and fragments thereof, wherein that g3p amino acid sequence has been modified through amino acid substitution to be substantially less immunogenic than the corresponding wild-type g3p amino acid sequence when used in vivo. The polypeptides of the invention retain their ability bind to and/or disaggregate amyloid. The invention relates furthermore to the use of these variant g3p- polypeptides in the treatment and/or prevention of diseases associated with misfolding or aggregation of amyloid.
申请公布号 MX2015016263(A) 申请公布日期 2016.04.18
申请号 MX20150016263 申请日期 2014.05.28
申请人 NEUROPHAGE PHARMACEUTICALS, INC. 发明人 TIMOTHY DAVID JONES;ROBERT GEORGE EDWARD HOLGATE;FRANCIS JOSEPH CARR;RICHARD A. FISHER
分类号 A61K38/16;A61K47/48;A61P25/28;C07K14/01 主分类号 A61K38/16
代理机构 代理人
主权项
地址